World Planet Information.Com
Clear World Information.

 

 

Kidney Cancer Information

Antisoma starts phase-II trial of AS1411 in kidney cancer (PharmaBiz)
Cancer drug developer Antisoma plc announced that it has started a phase-II study of AS1411 in metastatic renal cell carcinoma (kidney cancer).

Cancer center gets new director (The Star-Ledger)
Robert S. DiPaola left New Jersey for medical training in places such as Duke University and the University of Pennsylvania -- and then returned home in 1994 to help build the fledgling Cancer Institute of New Jersey.

NHS warned over cancer drugs cost (Evening Standard)
The high cost of cancer drugs could lead the NHS into "meltdown", a leading expert has said. Professor Karol Sikora said the next generation of drugs would keep people alive for longer but they were so expensive they could swallow half of the current NHS budget within four years.

Prostate cancer researcher tapped to lead Cancer Institute (The Star-Ledger)
The Cancer Institute of New Jersey has turned to one of its own doctors to lead the center. Robert S. DiPaola, a noted prostate cancer researcher already at the center, will be the new director of the New Brunwick institute, officials said.

Diabetics should undergo regular cancer screenings (EARTHtimes.org)
Wiesbaden, Germany - Doctors recommend diabetics undergo regular cancer screenings because not only are they at greater risk of developing kidney and circulatory disease, they also are at greater risk of developing tumours. Colon cancer is 30 per cen...

Cancer drugs costing £50billion will crush the NHS, says expert (Daily Mail)
The high cost of cancer drugs could lead the Health Service into meltdown, a medical expert has warned.

Antisoma Starts Phase II Study Of Kidney-cancer Drug (Fox News)
Antisoma Starts Phase II Study Of Kidney-cancer Drug

The Cancer Institute of New Jersey Welcomes New Director (Newswise)
Dr. Robert S. DiPaola named the new director of The Cancer Institute of New Jersey (CINJ), the state's only National Cancer Institute-designated Comprehensive Cancer Center.

(AFX UK Focus) 2008-09-09 06:31 Novartis cancer drug wins U.S. priority review (Interactive Investor)
LONDON, Sept 9 (Reuters) - An experimental drug from Swiss drugmaker Novartis AG has been granted priority review in the United States as a treatment for advanced kidney cancer. Novartis said on Tuesday that RAD001 or everolimus, which it plans to sell under the brand name Afinitor, had been accepted for fast review given the medicine's potential to help patients who fail to respond to standard ...

Diabetics should undergo regular cancer screenings (New Kerala)
Wiesbaden (Germany), Sep 8 : Doctors recommend diabetics undergo regular cancer screenings because not only are they at greater risk of developing kidney and circulatory disease, they also are at greater risk of developing tumours.

 

Pure Health Hoodia